The Environmental Case For Single-Use Systems

Evaluating manufacturing equipment requires looking beyond initial purchase prices and visible plastic waste to account for the hidden burdens of daily operation. Comprehensive life cycle assessments reveal that reusable stainless steel systems demand significant resources for cleaning, sterilization, and validation between batches, often consuming large amounts of purified water, steam, and energy. In contrast, single-use process technologies significantly reduce resource consumption and equipment downtime, accelerating production schedules and lowering overall operational expenses. By eliminating recurring cleaning requirements and validation cycles, facilities can optimize capital allocation and improve sustainability metrics across various workflows. Watch the full webinar to explore detailed environmental data, business case evaluations, and practical strategies for your facility.

Speakers:

Suresh Swaminathan, General Manager, Single Use & cGMP Chemicals, ILC Dover

Suresh Swaminathan serves as General Manager of Single Use & cGMP Chemicals at ILC Dover.He is passionate about helping customers accelerate innovation through advanced single-use technologies, process optimization, and supply chain solutions that support the development and production of life-saving therapies. Suresh gained his experience within the specialty chemical industry developing and commercializing novel solutions for the pharma and biopharma industries.

Luis Santos, Product Specialist, ILC Dover

Luis Santos is a Product Specialist at ILC Dover, where he supports the Powder Handling product family as a member of the Product Management team.

A Mechanical Engineering graduate from UCLA, Luis began his career as a Systems Engineer at Gilead Sciences working in Veklury, Gilead's COVID-19 response. He then took a role as a Systems Engineer at Tesla before transitioning back into the pharmaceutical industry as a Sales Engineer at ILC Dover.

Today, Luis manages ILC’s Powder Handling products through operations and pricing support for opportunities around the globe. His primary focus is on ILC’s GLP-1 initiative, helping to set commercial and product strategy for all opportunities related to the rapidly growing diabetes and weight loss drug industry.